233 related articles for article (PubMed ID: 25050468)
1. Induction of cytomegalovirus-specific T cell responses in healthy volunteers and allogeneic stem cell recipients using vaccination with messenger RNA-transfected dendritic cells.
Van Craenenbroeck AH; Smits EL; Anguille S; Van de Velde A; Stein B; Braeckman T; Van Camp K; Nijs G; Ieven M; Goossens H; Berneman ZN; Van Tendeloo VF; Verpooten GA; Van Damme P; Cools N
Transplantation; 2015 Jan; 99(1):120-7. PubMed ID: 25050468
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation.
Micklethwaite KP; Clancy L; Sandher U; Hansen AM; Blyth E; Antonenas V; Sartor MM; Bradstock KF; Gottlieb DJ
Blood; 2008 Nov; 112(10):3974-81. PubMed ID: 18768783
[TBL] [Abstract][Full Text] [Related]
3. Peptide vaccination in the presence of adjuvants in patients after hematopoietic stem cell transplantation with CD4+ T cell reconstitution elicits consistent CD8+ T cell responses.
Schmitt M; Schmitt A; Wiesneth M; Hückelhoven A; Wu Z; Kuball J; Wang L; Schauwecker P; Hofmann S; Götz M; Michels B; Maccari B; Wuchter P; Eckstein V; Mertens T; Schnitzler P; Döhner H; Ho AD; Bunjes DW; Dreger P; Schrezenmeier H; Greiner J
Theranostics; 2017; 7(6):1705-1718. PubMed ID: 28529646
[No Abstract] [Full Text] [Related]
4. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
[TBL] [Abstract][Full Text] [Related]
5. Efficient mRNA electroporation of peripheral blood mononuclear cells to detect memory T cell responses for immunomonitoring purposes.
Van Camp K; Cools N; Stein B; Van de Velde A; Goossens H; Berneman ZN; Van Tendeloo V
J Immunol Methods; 2010 Mar; 354(1-2):1-10. PubMed ID: 20138047
[TBL] [Abstract][Full Text] [Related]
6. The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB.
Lilja AE; Mason PW
Vaccine; 2012 Nov; 30(49):6980-90. PubMed ID: 23041121
[TBL] [Abstract][Full Text] [Related]
7. [T cell receptor β-chain CDR3 spectratyping and cytomegalovirus activation in allogeneic hematopoietic stem cell transplant recipients].
Wu Z; Jing M; Liang H; Yang R; Huang Y; Chen X; Hu J; Fan J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(5):515-521. PubMed ID: 28087912
[TBL] [Abstract][Full Text] [Related]
8. MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults.
La Rosa C; Longmate J; Martinez J; Zhou Q; Kaltcheva TI; Tsai W; Drake J; Carroll M; Wussow F; Chiuppesi F; Hardwick N; Dadwal S; Aldoss I; Nakamura R; Zaia JA; Diamond DJ
Blood; 2017 Jan; 129(1):114-125. PubMed ID: 27760761
[TBL] [Abstract][Full Text] [Related]
9. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection.
Gergely KM; Podlech J; Becker S; Freitag K; Krauter S; Büscher N; Holtappels R; Plachter B; Reddehase MJ; Lemmermann NAW
Front Immunol; 2021; 12():694588. PubMed ID: 34489940
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell vaccination in an allogeneic stem cell recipient receiving a transplant from a human cytomegalovirus (HCMV)-seronegative donor: induction of a HCMV-specific T(helper) cell response.
Feuchtinger T; Opherk K; Bicanic O; Schumm M; Grigoleit GU; Hamprecht K; Jahn G; Handgretinger R; Lang P
Cytotherapy; 2010 Nov; 12(7):945-50. PubMed ID: 20230226
[TBL] [Abstract][Full Text] [Related]
12. Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector.
Schleiss MR; Berka U; Watson E; Aistleithner M; Kiefmann B; Mangeat B; Swanson EC; Gillis PA; Hernandez-Alvarado N; Fernández-Alarcón C; Zabeli JC; Pinschewer DD; Lilja AE; Schwendinger M; Guirakhoo F; Monath TP; Orlinger KK
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27795301
[TBL] [Abstract][Full Text] [Related]
13. Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients.
Jacobson MA; Sinclair E; Bredt B; Agrillo L; Black D; Epling CL; Carvidi A; Ho T; Bains R; Adler SP
J Clin Virol; 2006 Mar; 35(3):332-7. PubMed ID: 16387547
[TBL] [Abstract][Full Text] [Related]
14. Clinical Usefulness of Monitoring Cytomegalovirus-Specific Immunity by Quantiferon-CMV in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Lee SM; Kim YJ; Yoo KH; Sung KW; Koo HH; Kang ES
Ann Lab Med; 2017 May; 37(3):277-281. PubMed ID: 28224776
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant Peptide Pulsed Dendritic Cell Vaccination in Addition to T Cell Adoptive Immunotherapy for Cytomegalovirus Infection in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Ma CKK; Clancy L; Simms R; Burgess J; Deo S; Blyth E; Micklethwaite KP; Gottlieb DJ
Biol Blood Marrow Transplant; 2018 Jan; 24(1):71-77. PubMed ID: 28864137
[TBL] [Abstract][Full Text] [Related]
16. Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation--a comparison of different assays for the detection of cytomegalovirus-specific T cells.
Abu-Khader A; Krause S
Eur J Haematol; 2013 Dec; 91(6):534-45. PubMed ID: 23952609
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus pp65 limits dissemination but is dispensable for persistence.
Malouli D; Hansen SG; Nakayasu ES; Marshall EE; Hughes CM; Ventura AB; Gilbride RM; Lewis MS; Xu G; Kreklywich C; Whizin N; Fischer M; Legasse AW; Viswanathan K; Siess D; Camp DG; Axthelm MK; Kahl C; DeFilippis VR; Smith RD; Streblow DN; Picker LJ; Früh K
J Clin Invest; 2014 May; 124(5):1928-44. PubMed ID: 24691437
[TBL] [Abstract][Full Text] [Related]
18. Inconsistent responses of cytomegalovirus-specific T cells to pp65 and IE-1 versus infected dendritic cells in organ transplant recipients.
Lilleri D; Zelini P; Fornara C; Comolli G; Gerna G
Am J Transplant; 2007 Aug; 7(8):1997-2005. PubMed ID: 17617865
[TBL] [Abstract][Full Text] [Related]
19. Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.
Nair SK; De Leon G; Boczkowski D; Schmittling R; Xie W; Staats J; Liu R; Johnson LA; Weinhold K; Archer GE; Sampson JH; Mitchell DA
Clin Cancer Res; 2014 May; 20(10):2684-94. PubMed ID: 24658154
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of human cytomegalovirus-specific T-cell response monitoring in predicting viremia in pediatric allogeneic stem-cell transplant patients.
Abate D; Cesaro S; Cofano S; Fiscon M; Saldan A; Varotto S; Mengoli C; Pillon M; Calore E; Biasolo MA; Cusinato R; Barzon L; Messina C; Carli M; Palù G
Transplantation; 2012 Mar; 93(5):536-42. PubMed ID: 22314338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
